Peter Pisters / LinkedIn
Jul 3, 2025, 18:26
Peter Pisters on The Cancer Letter Podcast: A Bold Vision for Pediatric Cancer Becomes Reality
MD Anderson Cancer Center recently reposted from Peters Pisters on LinkedIn.
”From the day Peter Pisters became president of UT MD Anderson nearly seven years ago, he wanted to do something “really big for pediatric cancer.” Listen to him talk to The Cancer Letter about how that dream is becoming a reality with the launch of Kinder Children’s Cancer Center.
Peter Pisters on LinkedIn:
‘As a sarcoma surgeon at UT MD Anderson Cancer Center, I often looked out the window at Texas Children’s Hospital and thought of the possibilities for collaborating to create a pediatric oncology center. After years of hearing that this was impossible, I am thrilled about our joint venture to launch Kinder Children’s Cancer Center and am proud of what we at MD Anderson are building with Debbie Sukin and her team at Texas Children’s, and I enjoyed talking with The Cancer Letter about it.’ ”
To read the full article and listen to the podcast follow the link.
The Cancer Letter welcomed Dr. Peter Pisters, president of MD Anderson Cancer Center, to discuss the “really big things” being done for pediatric cancer.
In the interview, Dr. Pisters shares a proud moment as he speaks about the joint initiative to launch the Kinder Children’s Cancer Center—now becoming a reality.
Also, he takes a moment to mention building some great things with Debbie Sukin and her team at Texas Children’s Hospital.
Not so impossible after all!
https://cancerletter.com/podcastc/20260701-pisters/
To read more winner stories in the field of hematology, stay tuned with Hemostasis Today.
-
Aug 26, 2025, 10:02Women’s Equality Day: HFA Recognizes Women with Bleeding Disorders
-
Aug 26, 2025, 09:59Rare Disease Advisor – RBC Rheology Alterations in Hemophilia with Arthropathy
-
Aug 26, 2025, 09:57HFA Supports Future Planning for People with Bleeding Disorders
-
Aug 26, 2025, 09:56Phillip Taboada: TXA Shows No Added Benefit in Aquablation
-
Aug 26, 2025, 09:50A Global Collaboration: PERT Consortium Expands Reach in PE Care
-
Aug 26, 2025, 09:54TSUBASA Study: Emicizumab Improves Daily Life and Motivation in Hemophilia A Patients
-
Aug 26, 2025, 09:38Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
-
Aug 26, 2025, 09:35Alexander Mazein: Innovative Insights into Cytokine Release Syndrome via a Novel Explorable Model for Biotherapeutics and Cellular Therapies
-
Aug 25, 2025, 10:40Maria Filomena Ruberto on The Hypercoagulable State
-
Aug 25, 2025, 09:19Parham Dastjerdi – Clonal Hematopoiesis and VTE Risk
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 26, 2025, 09:42David McIntosh Highlights Global Blood Shortages and Fresh vs Stored RBCs
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!
Aug 26, 2025, 10:02
Aug 26, 2025, 09:57
Aug 26, 2025, 09:56
Aug 26, 2025, 09:50
Aug 26, 2025, 09:42
Aug 26, 2025, 09:37